Novavax | NVAX - Ebitda





Ebitda Alterar Data
Adma Biologics USD 61.07M 12.52M 2026-03
Agenus USD -10.11M 19.02M 2025-03
AstraZeneca USD 5.16B 510M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Cassava Sciences USD -11.73M 33.44M 2025-09
Geron USD 3.83M 25.12M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
MannKind USD 2.93M 5.98M 2026-03
Merck USD -1.54B 7.84B 2026-03
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -1.26B 468M 2026-03
Novartis USD 5.41B 431M 2026-03
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.01B 18M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
TG Therapeutics USD 26.9M 1.21M 2026-06